Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. EOC dissemination is predominantly via direct extension of cells and multicellular aggregates (MCAs) into the peritoneal cavity, which adhere to and induce retraction of peritoneal mesothelium and proliferate in the submesothelial matrix to generate metastatic lesions. Metastasis is facilitated by the accumulation of malignant ascites (500 ml to >2 l), resulting in physical discomfort and abdominal distension, and leading to poor prognosis. Although intraperitoneal fluid pressure is normally subatmospheric, an average intraperitoneal pressure of 30 cmH2O (22.1 mmHg) has been reported in women with EOC. In this study, to enable experimental evaluation of the impact ...
Ovarian cancer cells are exposed to physical stress in the peritoneal cavity during both tumor growt...
Epithelial ovarian cancer (EOC) is usually discovered after extensive metastasis have developed in t...
The role of the epithelial-mesenchymal transition (EMT) in ovarian cancer cell progression is unques...
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. EOC dissemination is pr...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Unlike most epithelial malignancies which metastasize hematogenously, metastasis of epithelial ovari...
Ovarian cancers metastasize by shedding into the peritoneal fluid and dispersing to distal sites wit...
Epithelial ovarian cancer (EOC) will affect 1 in 69 women born in the United States today. Currently...
Ovarian cancer is often accompanied by severe ascites. This complication aggravates the disease per ...
Ovarian cancer remains a deadly diagnosis with an 85% recurrence rate and a 5-ye...
A major obstacle in ovarian cancer treatment is the onset of ascites, an abnormal build-up of fluid ...
The majority of women with ovarian cancer (EOC) are diagnosed with disseminated ip metastasis leadin...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
An early fundamental step in ovarian cancer progression is the dissemination of cancer cells through...
Epithelial ovarian cancer is the leading cause of death from gynecologic malignancy among women in d...
Ovarian cancer cells are exposed to physical stress in the peritoneal cavity during both tumor growt...
Epithelial ovarian cancer (EOC) is usually discovered after extensive metastasis have developed in t...
The role of the epithelial-mesenchymal transition (EMT) in ovarian cancer cell progression is unques...
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. EOC dissemination is pr...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Unlike most epithelial malignancies which metastasize hematogenously, metastasis of epithelial ovari...
Ovarian cancers metastasize by shedding into the peritoneal fluid and dispersing to distal sites wit...
Epithelial ovarian cancer (EOC) will affect 1 in 69 women born in the United States today. Currently...
Ovarian cancer is often accompanied by severe ascites. This complication aggravates the disease per ...
Ovarian cancer remains a deadly diagnosis with an 85% recurrence rate and a 5-ye...
A major obstacle in ovarian cancer treatment is the onset of ascites, an abnormal build-up of fluid ...
The majority of women with ovarian cancer (EOC) are diagnosed with disseminated ip metastasis leadin...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
An early fundamental step in ovarian cancer progression is the dissemination of cancer cells through...
Epithelial ovarian cancer is the leading cause of death from gynecologic malignancy among women in d...
Ovarian cancer cells are exposed to physical stress in the peritoneal cavity during both tumor growt...
Epithelial ovarian cancer (EOC) is usually discovered after extensive metastasis have developed in t...
The role of the epithelial-mesenchymal transition (EMT) in ovarian cancer cell progression is unques...